{
    "2018-08-07": [
        [
            {
                "time": "2018-01-02",
                "original_text": "This Midcap Biotech Popped Nearly 20% On Hope In Cancer, Inflammation",
                "features": {
                    "keywords": [
                        "Midcap Biotech",
                        "Popped",
                        "Cancer",
                        "Inflammation"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-31",
                "original_text": "Examining Pfizer’s Performance by Segment in Q2 2018",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Performance",
                        "Segment",
                        "Q2 2018"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-08-02",
                "original_text": "Ligand (LGND) Beats on Q2 Earnings & Revenues, Raises View",
                "features": {
                    "keywords": [
                        "Ligand",
                        "Earnings",
                        "Revenues",
                        "Raises View"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-03",
                "original_text": "Teva’s Granix Gets FDA Approval for Expanded Indication",
                "features": {
                    "keywords": [
                        "Teva",
                        "Granix",
                        "FDA Approval",
                        "Expanded Indication"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-01",
                "original_text": "The Swiss Stock Market Climbed As Trade Concerns Relax",
                "features": {
                    "keywords": [
                        "Swiss Stock Market",
                        "Climbed",
                        "Trade Concerns",
                        "Relax"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-02",
                "original_text": "Mylan Stock Trending Higher before Its Q2 2018 Results",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Stock",
                        "Trending Higher",
                        "Q2 2018 Results"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}